Quick Answer
NovaBridge Biosciences reported Total Assets of $212.68 million for fiscal year 2024.
NovaBridge Biosciences Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $212.68M | -42.4% |
| 2023 | $368.92M | -90.9% |
| 2022 | $4.07B | -27.3% |
| 2021 | $5.60B | -11.6% |
| 2020 | $6.33B | +264.5% |
| 2019 | $1.74B | -26.9% |
| 2018 | $2.38B | — |
- NovaBridge Biosciences showed a decrease of -42.4% in Total Assets compared to the prior fiscal year.
- Over the 2018–2024 period, NovaBridge Biosciences’s total assets has declined by 91.0% (from $2.38 billion to $212.68 million).
- The most recent figure is from NovaBridge Biosciences’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: